Cardiomyopathy Clinical Trials

Find Cardiomyopathy Clinical Trials Near You

Safety and Efficacy of Non-invasive and Ambulatory Hemodynamic Monitoring for Evaluating the Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This study aimed to evaluate the efficacy of non-invasive dynamic blood pressure monitoring in assessing left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. We prospectively collected SBP waveforms and LVOT gradient data from patients with obstructive and non-obstructive disease, systematically analyzed their correlation, and explored its clinical value in different clinical scenarios.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• 2: ② Diagnosed with hypertrophic cardiomyopathy (HCM) by echocardiography, with or without left ventricular outflow tract obstruction

• 3: ③ Conscious and mentally competent, able to understand and voluntarily sign the informed consent form

• 4: ④ Able to cooperate with the completion of provocation tests, non-invasive dynamic hemodynamic monitoring, and relevant follow-up examinations.

• \-

Locations
Other Locations
China
Zhongshan Hospital
RECRUITING
Shanghai
Contact Information
Primary
Ziqing Yu, PhD
yu.ziqing@zs-hospital.sh.cn
+86 18833221133
Time Frame
Start Date: 2025-12-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 800
Treatments
HCM
HCM patients
Sponsors
Leads: Shanghai Zhongshan Hospital

This content was sourced from clinicaltrials.gov